Inventera Inc. (KOSDAQ:0007J0)

Market Cap	180.12B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	171,473
Average Volume	3,184,276
Open	23,000
Previous Close	22,900
Day's Range	22,800 - 24,200
52-Week Range	20,000 - 60,200
Beta	n/a
RSI	25.27
Earnings Date	n/a

About Inventera

Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 0007J0